MIMS Indonesia
source

MIMS Indonesia

Price
Free
Category
Medical Utilities
Last update
Mar 09, 2026
Publisher
MIMS PTE. LTD. Contact publisher
View in store
Loading...

Ratings & Reviews performance

Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.

Loading...

Description

1506 chars

For over 50 years, MIMS has provided trusted clinical information for over 2 million healthcare professionals in Asia. Designed for busy individuals on the go, the MIMS app is a one-stop medical resource to support clinical decisions at the point of care. The most trusted drug and medical reference tool for doctors in Asia. The MIMS Mobile app for IOS™ is available for free. For more information, visit www.mims.com/mobile-app __________________________________________________________________ Key features available in our app: • Drug Information Search for drug dosing information or specific drug interactions, and find the answers you need in seconds with our concise and comprehensive drug database. • Disease & Condition Management Guidelines Review a complete disease management guide and be assured of reliable content fully substantiated by validated references and internationally recognised research, to enable you to make better-informed prescribing decisions. • Medical News & CME Updates Read the latest news available across various specialties in Asia through our renowned publications (Medical Tribune, JPOG, Oncology Tribune, etc), and keep your knowledge and skills current with changes in medicine. • Multimedia Watch insightful video interviews focusing on treatment options, disease management and latest updates by experts from various specialties, and upgrade your medical knowledge. If you have any feedback for MIMS mobile app, you can send them to bit.ly/mimsiosID

Screenshots

https://is1-ssl.mzstatic.com/image/thumb/Purple113/v4/eb/05/d7/eb05d76b-02f2-a0af-518e-865063567d4a/pr_source.jpg/2048x2732.pnghttps://is1-ssl.mzstatic.com/image/thumb/Purple123/v4/05/21/ad/0521ad05-2ce8-84cc-f447-d77f82dce315/pr_source.jpg/2048x2732.pnghttps://is1-ssl.mzstatic.com/image/thumb/Purple113/v4/1e/83/78/1e837820-86e9-0293-13cf-fbb45172916e/pr_source.jpg/2048x2732.pnghttps://is1-ssl.mzstatic.com/image/thumb/Purple123/v4/8b/9e/d8/8b9ed8d1-e34d-706f-1e75-56bd6db22678/pr_source.jpg/2048x2732.pnghttps://is1-ssl.mzstatic.com/image/thumb/Purple113/v4/ad/47/90/ad479015-6651-1b13-2907-9323567b3ba0/pr_source.jpg/2048x2732.pnghttps://is1-ssl.mzstatic.com/image/thumb/Purple123/v4/50/04/9d/50049d1e-d910-571e-e7f0-ef3821826125/pr_source.jpg/2048x2732.png
Loading...
Loading...

Find growth insights on our blog

React to user feedback and market trends faster